DiamiR Announces Oral Presentation on Recent Advances of Its microRNA Biomarker Platform at 2024 International Rett Syndrome Foundation Scientific Meeting

NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., June 12, 2024 /PRNewswire/ — DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that the company’s co-founder Dr. Kira Sheinerman will present at the 2024 International Rett Syndrome Foundation (IRSF) Rett Syndrome Scientific Meeting, taking place June 18-19, 2024, in Westminster, CO.

Talk Title: Circulating brain-enriched microRNAs as biomarkers of Rett syndrome
Session Title: Biomarkers & Behavior Studies
Session Date and Time: Tuesday, June 19, 2024 at 2:30 pm MDT
Location: The Westin Westminster, Westminster Ballroom